Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.080
+0.030 (1.46%)
Mar 6, 2026, 4:00 PM EST - Market closed
Compugen Employees
Compugen had 74 employees as of December 31, 2024. The number of employees increased by 6 or 8.82% compared to the previous year.
Employees
74
Change (1Y)
6
Growth (1Y)
8.82%
Revenue / Employee
$983,297
Profits / Employee
$477,608
Market Cap
194.55M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Editas Medicine | 246 |
| Arcturus Therapeutics Holdings | 176 |
| ProQR Therapeutics | 166 |
| Molecular Partners AG | 153 |
| Heron Therapeutics | 128 |
| Tenaya Therapeutics | 97 |
| Acumen Pharmaceuticals | 61 |
| Elicio Therapeutics | 32 |
CGEN News
- 5 days ago - Compugen Reports Fourth Quarter and Full Year 2025 Results - PRNewsWire
- 16 days ago - Compugen to Participate in Upcoming Investor Conferences - PRNewsWire
- 18 days ago - Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026 - PRNewsWire
- 23 days ago - Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors - PRNewsWire
- 2 months ago - Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million - PRNewsWire
- 4 months ago - Compugen Reports Third Quarter 2025 Results - PRNewsWire
- 4 months ago - Compugen to Participate in Stifel 2025 Healthcare Conference - PRNewsWire
- 4 months ago - Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 - PRNewsWire